Overview

Vyvanse in Children Aged 6 to 12 Years

Status:
Not yet recruiting

Trial end date:
2029-06-30

Target enrollment:

Participant gender:

Summary

This study will randomize children who have difficulty maintaining a healthy weight to one of two treatment groups: lifestyle therapy plus lisdexamfetamine or lifestyle therapy plus placebo.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Minnesota

Treatments:

Lisdexamfetamine Dimesylate